| ROYALTY PHARMA OA DL-0001 |
| Großbritannien |
| Gesundheit |
| GB00BMVP7Y09 / A2P62D |
| RPD (Frankfurt) / RPRX (NASDAQ) |
| FRA:RPD, ETR:RPD, RPD:GR, NASDAQ:RPRX |
| - |
| https://www.royaltypharma.. |
|
Royalty Pharma plc is the world's largest buyer of biopharmaceutical royalties and a leading funder of innovation in the life sciences sector. The company acquires royalties entitling it to payments based on net sales of approved therapies and develo..
>Volltext.. |
| 24234.46 Mio. EUR |
| 34078.82 Mio. EUR |
| 2060.27 Mio. EUR |
| 1352.85 Mio. EUR |
| 667.71 Mio. EUR |
| 1.55 EUR |
| 7768.26 Mio. EUR |
| 535.99 Mio. EUR |
| 2248.06 Mio. EUR |
| 1 |
| -7.41% |
| -20.89% |
| 0.77 EUR |
| 1.93% |
| 2.02% |
| 20.02.26 - 0.1993975€ 14.11.25 - 0.189244€ >weitere anzeigen... |
| ROYALTY PHARMA |
| 04.04.26 |